69 reports

  • OVERVIEW
  • 35% of the market share comes from culture

About Tuberculosis (TB) Diagnostics TB is a contagious infection that usually attacks the lungs. It may also spread to other parts of the body such as the brain and the spine. TB commonly spreads through the air when an infected person coughs, sneezes, spits, laughs, or talks. Mycobacterium tuberculosis is responsible for the...

  • Tuberculosis
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Global Tuberculosis (TB) Drugs Market is Expected to Grow to $1,035.67 mn by 2021
  • 2.1 Preface

About Tuberculosis Drug Tuberculosis (TB) is caused by Mycobacterium tuberculosis and often affects the lungs. It spreads from person to person through the air in the form of a cough, sneeze or spit. TB affects adults more when compared with children. Technavio’s analysts forecast the global tuberculosis drug market to...

  • Pathology
  • Tuberculosis
  • World
  • Forecast
  • Sandoz Inc.
  • Profiles of Tuberculosis Drugs Producers
  • Tuberculosis Treatment Drugs Market Overview

China’s demand for Tuberculosis Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Tuberculosis
  • China
  • Demand
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Tuberculosis Treatment Drugs Market Overview
  • Tuberculosis Treatment Drugs Market Overview

This study focuses on China’s Tuberculosis Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Tuberculosis
  • China
  • Demand
  • Trade
  • Chongqing Huapont Pharmaceutical Co., Ltd
  • Profiles of Tuberculosis Drugs Producers
  • Chapter VII TUBERCULOSIS TREATMENT DRUGS PRODUCER DIRECTORY

This study focuses on China’s Tuberculosis Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Tuberculosis
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Shenyang Shuangding Pharmaceutical Co., Ltd.

Global Tuberculosis Testing Market: Trend Analysis and Forecast to 2022 ##.

  • Pathology
  • Tuberculosis
  • APAC
  • World
  • Forecast

Tuberculosis Testing Market, Nucleic Acid Testing, Xpert Test, Serological Tests, and Smear Microscopy - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025 Section ## Preface ##. ##.

  • Pathology
  • Tuberculosis
  • APAC
  • World
  • Company Financials

Global Tuberculosis Diagnosis and Treatment Market Research and Forecast 2017-2022 ##.

  • Pathology
  • Tuberculosis
  • World
  • Market Size

Based on Type, the market is categorized into Latent Tuberculosis, Active Tuberculosis and Drug-resistant Tuberculosis.

  • Anti-Infective
  • Tuberculosis
  • World
  • Forecast
  • Market Size

One unit refers to one Mycobacterium Diagnostic test.

  • Tuberculosis
  • Australasia
  • Demand
  • Market Size
  • Supply

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • World
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Tuberculosis
  • Europe
  • Japan
  • United States
  • Demand

Based on Therapeutics the market is categorized into Tuberculosis Drugs (First Line) and Tuberculosis Drugs (Second Line).

  • Therapy
  • Tuberculosis
  • United States
  • World
  • Forecast

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Forecast

Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment.

  • Diagnostics
  • Pathology
  • Tuberculosis
  • United States
  • Market Size

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Infectious Disease
  • Respiratory Disease
  • Tuberculosis
  • Europe
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Forecast
  • APAC Tuberculosis Vaccines Market
  • APAC Tuberculosis Vaccines Market Overview

Executive Summary Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand...

  • Tuberculosis
  • World
  • Market Size
  • Merck & Co., Inc.
  • Sanofi S.A.
  • 2.4.4 Tuberculosis
  • Infections and Tuberculosis

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Summary Respiratory complications are a diverse set of indications that include respiratory disorders, cardiovascular disorders and infectious diseases. They...

  • Tuberculosis
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.
  • Epistem Holdings Plc Pipeline Products by Indication
  • Oct 28, 2014: Successful completion of Genedrive Indian clinical trials and regulatory submission

Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a biopharmaceutical and biotechnology company is a molecular diagnostics company which also provides contract research services to other pharmaceutical companies. It also undertakes the development of novel therapies for cancer treatment and wound healing. It provides...

  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company
  • TUBERCULOSIS VACCINE
  • Tuberculosis - Drug Profiles

Tuberculosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2017, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.
  • DESCRIPTION OF INFECTIONS
  • GLOBAL POPULATION AT RISK FOR SERIOUS BACTERIAL INFECTIONS, SECONDARY TO CHRONIC DISEASES BY SELECTED GEOGRAPHICAL REGION

One third of the world' s current population has been infected with M. tuberculosis, and new infections occur at a rate of one per second.

  • Tuberculosis
  • Cepheid
  • Getinge Group
  • Roche Group
  • STERIS Corporation
  • MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2018*
  • MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2018*

Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium tuberculosis Infections clinical trials scenario.This report...

  • Anti-Infective
  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World
  • tuberculosis vaccine - Drug Profile
  • tuberculosis vaccine - Drug Profile

Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016’, provides in depth analysis on Mycobacterium tuberculosis Protein Ag85A targeted pipeline therapeutics. The report provides comprehensive information...

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative
  • DRUG FOR TUBERCULOSIS
  • TUBERCULOSIS VACCINE - DRUG PROFILE

Tuberculosis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H1 2018, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • United States
  • TB Drug Development, Inc.
  • TUBERCULOSIS VACCINE - DRUG PROFILE
  • TUBERCULOSIS VACCINE - DRUG PROFILE

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016’, provides in depth analysis on Mycobacterium...

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative
  • Pulmonary Tuberculosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Pulmonary Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary...

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Product Initiative